The BSH Guidelines Official Podcast

By British Society for HaematologyScience Medicine Health & Fitness Education

The BSH Guidelines Official Podcast episodes

September 11 Use of andexanet alfa: A British Society for Haematology position statement
During this podcast, Dr Richard Buka and Prof Deepa Arachchillage discuss the BSH Position Paper ‘Use of andexanet alfa: A British Society for Haematology position statement', published in April 2026.
26 min
September 08 Reporting haemostasis assays in IU/dL—A recommendation for harmonisation (BSH H&T Task Force / UK NEQAS / UK HCDO)
Dr Will Lester and Dr Ian Jennings discuss the Reporting haemostasis assays in IU/dL—A recommendation for harmonisation (BSH H&T Task Force / UK NEQAS / UK HCDO) paper, published in July 2025.
17 min
August 21 BSH guideline for the estimation of fetomaternal haemorrhage
During this podcast, Matthew Hazell and Lynne Porter discuss the guideline for the estimation of fetomaternal haemorrhage, published in 2026.
27 min
April 09 Investigation and management of thrombocytosis without JAK2, CALR or MPL mutations Guideline
During this podcast, Anna Godfrey discusses the Investigation and management of thrombocytosis without JAK2, CALR or MPL mutations Guideline, published in 2025.
22 min
April 09 Guideline for the treatment of chronic lymphocytic leukaemia 2025
During this podcast, Piers Patten and Renata Walewska discuss the Guideline for the treatment of chronic lymphocytic leukaemia, published in 2025.
32 min
March 06 Guidelines for the diagnosis and management of adult aplastic anaemia
During this podcast, Dr Austin Kulasekararaj and Dr Lugain Abdalla discuss the Guidelines for the diagnosis and management of adult aplastic anaemia, published in 2024.
34 min
January 30 Guideline on investigating and managing acquired coagulation factor inhibitors: Joint BSH–UKHCDO guidance
In this episode, Dr Charles Percy discusses the joint British Society for Haematology and United Kingdom Haemophilia Centre Doctors' Organisation Guideline on 'Laboratory investigation and clinical management of acquired coagulation factor inhibitors', published in 2025.
25 min
December 08, 2025 Updated guidelines for the diagnosis and management of tumour lysis syndrome in adults and children
Dr Tracey Chan and Dr Dima El-Sharkawi discuss the Updated guidelines for the diagnosis and management of tumour lysis syndrome in adults and children, published in 2025.
21 min
December 08, 2025 Clinical management of bispecific antibody therapy for lymphoma Guideline podcast
Dr Matthew Wilson, Dr Sridhar Chaganti and Dr Wendy Osborne discuss the Clinical management of bispecific antibody therapy for lymphoma Good Practice Paper, published in 2025.
36 min
November 07, 2025 Lymphoma SIG Podcast Episode 16 Choosing the optimal therapy in CLL – by Dr Toby Eyre
Dr Eyre is a consultant haematologist specialising in lymphoid malignancies in Oxford.
He has completed an MD Doctorate Thesis in 2017. He is an investigator on several national lymphoid trials and has published over 170 peer-review articles on lymphoma and CLL. He is the chair of the low-grade lymphoma clinical trial research group and a core member several lymphoma study groups. He is a member of the BSH guideline writing groups for various lymphoma subtypes and the lead author for the new ESMO Lymphoma guidelines. He is also an Associate Editor at the British Journal of Haematology.
30 min

About The BSH Guidelines Official Podcast

From the publisher's feed

Written by expert consultants and clinical scientists currently practising in the UK, the BSH Guidelines provide up-to-date evidence-based guidance on the diagnosis and treatment of haematological diseases.